Page 65 - GPD-3-2

Gene & Protein in Disease TOPK: Target for lung cancer treatment

and is associated with poor prognosis in lung cancer. 31. Gao T, Hu Q, Hu X, et al. Novel selective TOPK inhibitor
Oncogene. 2012;31(19):2389-2400. SKLB-C05 inhibits colorectal carcinoma growth and
doi: 10.1038/onc.2011.419 metastasis. Cancer Lett. 2019;445:11-23.
21. Park JH, Moon M, Kim JS, Oh SM. TOPK mediates hypoxia- doi: 10.1016/j.canlet.2018.12.016
induced epithelial-mesenchymal transition and the invasion 32. Zhao R, Huang H, Choi BY, et al. Cell growth inhibition by
of nonsmall-cell lung cancer cells via the HIF-1α/snail axis. 3-deoxysappanchalcone is mediated by directly targeting the
Biochem Biophys Res Commun. 2021;534:941-949. TOPK signaling pathway in colon cancer. Phytomedicine.
doi: 10.1016/j.bbrc.2020.10.068 2019;61:152813.
22. Xiao J, Wang F, Lu H, et al. Targeting the COX2/MET/ doi: 10.1016/j.phymed.2018.12.036
TOPK signaling axis induces apoptosis in gefitinib-resistant 33. Fu X, Zhao R, Yoon G, et al. 3-Deoxysappanchalcone inhibits
NSCLC cells. Cell Death Dis. 2019;10(10):777. skin cancer proliferation by regulating T-lymphokine-
doi: 10.1038/s41419-019-2020-4 activated killer cell-originated protein kinase in vitro and in
vivo. Front Cell Dev Biol. 2021;9:638174.
23. Wei DC, Yeh YC, Hung JJ, et al. Overexpression of T-LAK
cell-originated protein kinase predicts poor prognosis in doi: 10.3389/fcell.2021.638174
patients with stage I lung adenocarcinoma. Cancer Sci. 34. Gao G, Zhang T, Wang Q, et al. ADA-07 suppresses
2012;103(4):731-738.
solar ultraviolet-induced skin carcinogenesis by directly
doi: 10.1111/j.1349-7006.2011.02197.x inhibiting TOPK. Mol Cancer Ther. 2017;16(9):1843-1854.
24. Lei B, Liu S, Qi W, et al. PBK/TOPK expression in non- doi: 10.1158/1535-7163.Mct-17-0212
small-cell lung cancer: Its correlation and prognostic
significance with Ki67 and p53 expression. Histopathology. 35. Zhao R, Choi BY, Wei L, et al. Acetylshikonin suppressed
2013;63(5):696-703. growth of colorectal tumour tissue and cells by inhibiting
the intracellular kinase, T-lymphokine-activated
doi: 10.1111/his.12215 killer cell-originated protein kinase. Br J Pharmacol.
25. Lei B, Qi W, Zhao Y, et al. PBK/TOPK expression correlates 2020;177(10):2303-2319.
with mutant p53 and affects patients’ prognosis and cell doi: 10.1111/bph.14981
proliferation and viability in lung adenocarcinoma. Hum
Pathol. 2015;46(2):217-224. 36. Zhang E, Yin S, Lu X, Ye L, Fan L, Hu H. Glycycoumarin
sensitizes liver cancer cells to ABT-737 by targeting de
doi: 10.1016/j.humpath.2014.07.026 novo lipogenesis and TOPK-survivin axis. Nutrients.
26. Li J, Hou W. Expression patterns and clinical significances 2018;10(3):353.
of PBK in lung cancer: An analysis based on Oncomine doi: 10.3390/nu10030353
database. Transl Cancer Res. 2021;10(5):2036-2043.
37. Zeng X, Liu L, Zheng M, et al. Pantoprazole, an FDA-
doi: 10.21037/tcr-20-3435 approved proton-pump inhibitor, suppresses colorectal
27. Ma H, Zhang J, Shi Y, et al. PBK correlates with prognosis, cancer growth by targeting T-cell-originated protein kinase.
immune escape and drug response in LUAD. Sci Oncotarget. 2016;7(16):22460-22473.
Rep. 2023;13(1):20452.
doi: 10.18632/oncotarget.7984
doi:10.1038/s41598-023-47781-7
38. Zheng M, Luan S, Gao S, et al. Proton pump inhibitor ilaprazole
28. Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: suppresses cancer growth by targeting T-cell-originated
New biological insights and recent therapeutic advances. CA protein kinase. Oncotarget. 2017;8(24):39143-39153.
Cancer J Clin. 2011;61(2):91-112.
doi: 10.18632/oncotarget.16609
doi: 10.3322/caac.20102
39. Vishchuk OS, Sun H, Wang Z, et al. PDZ-binding kinase/T-
29. Wang M, Herbst RS, Boshoff C. Toward personalized LAK cell-originated protein kinase is a target of the fucoidan
treatment approaches for non-small-cell lung cancer. Nat from brown alga Fucus evanescens in the prevention of EGF-
Med. 2021;27(8):1345-1356. induced neoplastic cell transformation and colon cancer
doi: 10.1038/s41591-021-01450-2 growth. Oncotarget. 2016;7(14):18763-18773.
30. Matsuo Y, Park JH, Miyamoto T, et al. TOPK inhibitor doi: 10.18632/oncotarget.7708
induces complete tumor regression in xenograft models of 40. Diao X, Yang D, Chen Y, Liu W. Baicalin suppresses
human cancer through inhibition of cytokinesis. Sci Transl lung cancer growth by targeting PDZ-binding
Med. 2014;6(259):259ra145. kinase/T-LAK cell-originated protein kinase. Biosci
doi: 10.1126/scitranslmed.3010277 Rep. 2019;39(4):BSR20181692.

Volume 3 Issue 2 (2024) 9 doi: 10.36922/gpd.3062